CEO John Rademacher purchases 12,500 shares of OPCH amid sharp recent decline from highs.
CEO John Rademacher is buying Option Care Health stock after a significant pullback from its highs, reducing his exposure to equity losses and signaling confidence in the company's recovery potential. The timing is notable: the stock has declined sharply from its recent peak, yet Rademacher is deploying capital into the company he runs, which typically reflects insider conviction that the selloff is overdone. Option Care Health remains profitable with solid revenue growth, so Rademacher isn't catching a broken business—he's buying into a fundamentally sound operator during a weakness. This kind of C-suite buying during pullbacks is a credible signal of management's belief in value, though a single purchase by one executive is less powerful than a coordinated wave of insider accumulation.